Yue Li
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The shifting global thalassemia burden and lessons from Chineseintegrated control strategy.
Journal: iScience
Published: March 18, 2026
Safety and efficacy of hemobeglogene autotemcel(hemo-cel) gene therapy in five patients with transfusion-dependent β-thalassemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: July 15, 2025
A Population Pharmacokinetics Model of Busulfan in Pediatric Patients with Thalassemia Major.
Journal: Current drug metabolism
Published: May 08, 2025
Clinical characteristics of cytokine release syndrome after haploidentical hematopoietic stem cell transplantation for thalassemia major
Journal: Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics
Published: December 26, 2024
Surveillance and Outcomes of Pediatric Hematopoietic Stem Cell Transplantation Recipients During the Recent COVID-19 Outbreak in China.
Journal: Infection and drug resistance
Published: June 26, 2023
Co-Transplantation of Haploidentical Stem Cells and a Dose of Unrelated Cord Blood in Pediatric Patients with Thalassemia Major.
Journal: Cell transplantation
Published: February 17, 2021
Restoration of β-Globin Expression with Optimally Designed Lentiviral Vector for β-Thalassemia Treatment in Chinese Patients.
Journal: Human gene therapy
Published: December 01, 2020
Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China.
Journal: BMC pediatrics
Published: July 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026